Evidence map›Paper›PMID 41719547›Full record

ArticleJMIR medical informatics2026

Ensemble Machine Learning Models for Predicting Patients With High Usage: Model Validation and Economic Impact Analysis.

Joshua Kuan Tan, Le Quan, Hao Yi Tan, Su-Yen Goh, Julian Thumboo, Marianne Au, Yong Mong Bee, Jen Hong Tan

Abstract read
In one paragraph

Article in JMIR medical informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joshua Kuan Tan *Health Services Research Unit, Singapore General Hospital, Singapore, Singapore.ORCID 0000-0002-4518-0477
Le Quan *Data Science and Artificial Intelligence Laboratory, Singapore General Hospital, Singapore, Singapore.ORCID 0009-0002-3306-3000
Hao Yi Tan *Health Services Research Unit, Singapore General Hospital, Singapore, Singapore.ORCID 0009-0005-8904-8936
Su-Yen Goh *Future Health Systems Department, Singapore General Hospital, Singapore, Singapore.ORCID 0000-0003-3758-9982
Julian Thumboo *Health Services Research Unit, Singapore General Hospital, Singapore, Singapore.ORCID 0000-0001-6712-5535
Marianne Au *Group Finance, SingHealth, Singapore, Singapore.ORCID 0000-0003-3653-0962
Yong Mong Bee *Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.ORCID 0000-0002-5482-2646
Jen Hong Tan *Data Science and Artificial Intelligence Laboratory, Singapore General Hospital, Singapore, Singapore.ORCID 0000-0002-7785-2987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMachine learning models are increasingly used to predict patients at risk of high health care usage for targeted interventions.

objectiveThis study aimed to evaluate the predictive performance of multiclass ensemble models across different levels of health care usage and assess their potential application through real-world economic impact analysis.

methodsA total of 4 previously developed binary classification models (base learners)-boosted trees, multivariate adaptive regression splines, multilayer perceptron, and logistic regression-were extended using a stacking ensemble approach. These base learner models generated individual-level predicted probabilities, which were used as inputs to build multiclass prediction models forecasting usage across defined strata: length of stay (LOS) of <7, 7-13, 14-29, and ≥30 days, and emergency department (ED) visits of <3, 3-4, 5-9, and ≥10 visits. In total, 3 ensemble algorithms were evaluated: random forest, boosted trees, and linear support vector machines. Ensemble models were trained on registry data from 2020-2021 and temporally validated on 2021-2022 data. Performance was assessed using multiclass area under the receiver operating curve, accuracy, and confusion matrix-derived metrics. Economic impact was estimated via Monte Carlo simulations using inpatient billing data, assuming a 20% cost reduction in the following year.

resultsThe models were trained on 108,886 patients and validated on 111,004 patients. Among all ensemble configurations, boosted tree models regardless of base learner achieved the highest performance, with multiclass area under the receiver operating curve scores of 0.6877 (95% CI 0.6927-0.7255) for LOS and 0.7601 (95% CI 0.7301-0.7654) for ED visits, and corresponding accuracies of 0.6522 (95% CI 0.6465-0.6579) and 0.7457 (95% CI 0.7405-0.7508), respectively. In the validation set, these models correctly assigned 30.3% of inpatient LOS and 39.8% of ED visits to the correct class, identifying 77% of future inpatient users and 73.9% of future ED users. Economic impact analysis for LOS identified the boosted tree model with logistic regression base learner as dominant, achieving a simulated average cost reduction of SGD $152 million (US $111 million), SGD $2.4 million (US $1.75 million; 1.5%) more than the next best model using a multilayer perceptron base learner.

conclusionsEnsemble models can effectively predict multilevel health care usage and potentially generate meaningful cost savings when applied to real-world settings. These models may support targeted interventions and guide planning and budgeting in diabetes-related population health programs.

Indexed as

Machine LearningBoosting Machine Learning AlgorithmsClassification AlgorithmsEnsemble LearningHumansLength of StayPrediction AlgorithmsPredictive Learning ModelsRandom ForestROC Curveartificial intelligencedecision analysisdiabetes mellituseconomic analysishealthcare utilizationMonte Carlo simulationpopulation health management, machine learning

Identifiers

PMID41719547
PMCPMC12966819

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.